Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Medical Device Caused Brain Damage, Lawsuit Alleges

The device may have been part of a previous recall by the FDA.

A Washington state man is suing Penumbra, claiming their Coil 400 medical device used to treat his aneurysm malfunctioned and caused him to suffer brain damage, according to the Associated Press.

According to the article, the lawsuit claims, "the doctor placed 90 percent of the coil into the aneurysm, but the last 10 percent got stuck in the intracranial artery."

The doctor was not able to remove the coil, which detached prematurely and remained, along with a stent, in the man's brain, causing him to suffer a stroke, according to the article.

In 2011, about 267 lots of Penumbra Coil 400 products were involved in a Class I recall by the FDA, who said, according to the article, "that it found that the pull wire on the delivery tool could slip out of place and allow premature detachment of the Coil 400."

A year later in 2012, the agency gave clearance to Penumbra to market the device again. The device in question was manufactured on Aug. 11, 2011 and had an expiration date of Aug. 31, 2013, according to the lawsuit.

The pateint's lawyer told the Associated Press, "they are trying to determine whether the device was one of the recalled coils, or if the new ones have the same problem."

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?